HER2+ Colorectal Cancer: Slicing the Pie Into Curable PortionsHER2+ Colorectal Cancer: Slicing the Pie Into Curable Portions

Dr John Marshall views a study of dual targeting in HER2+ CRC as an argument for combining broad molecular testing and precision medicine to slice the cancer pie into curable portions. Medscape Oncology

Source: Medscape Today Headlines - May 23, 2016 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news